Clinical trial on effect of Shigru tail nasya in Migraine.

Open Clinical Trial on Shigru Tail Nasya in Ardhavabhedaka with special reference to Migraine. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064345

Enrollment

Registered

2024-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients complaining symptoms of ardhavbhedak 2. patient fit for Nasya karma. 3. Patient willing to participate.

Exclusion criteria

Exclusion criteria: 1. patients with disorders of eye, ear, nose, throat, and teeth. 2. Patients with complications. 3. Known cases of systemic disease and immunosuppressive disorders.

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Shigru tail nasya in the management of Ardhavabhedaka with special refence to Migraine.Timepoint: Patients will be assessed on pain giddiness nausea and vomiting scale on 0th day 8th day 22nd day and 30th day	—

Secondary

Measure	Time frame
Assessment of sigru taila nasya on symptoms of migraine such as headache, giddiness, nausea, & vomiting on the basis of ordinal scaleTimepoint: patients will be assessed on 0th day 8th day 22nd day & 30th day	—

Countries

India

Contacts

Public ContactDR Vijwade A P

Government Ayurveda College Nagpur

drapvaijwade@gmail.com9421756462

Outcome results